ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2025

Clinical Characteristics and Therapy Response in a Large Single-Centre Cohort of Patients with Periodic Fever with Aphtous Stomatitis, Pharyngitis and Cervical Adenitis Syndrome

Francesca Ricci1, Antonella Meini1, Lucio Verdoni2, Laura Dotta1, Marta Bolis2, Marco Berlucchi3, Gianfranco Savoldi4 and Marco Cattalini2, 1Pediatric Clinic, University of Brescia and Spedali Civili di Brescia, Pediatric Immunology and Rheumatology Unit, Brescia, Italy, 2Pediatric Clinic, Spedali Civili di Brescia and University of Brescia, Pediatric Immunology and Rheumatology Unit, Brescia, Italy, 3Spedali Civili di Brescia, Department of Pediatric Otorhinolaryngology, Brescia, Italy, 4Spedali Civili di Brescia, Angelo Nocivelli Institute of Molecular Medicine, Brescia, Italy

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Diagnostic criteria, Fever, pediatric rheumatology and steroids

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: PFAPA (Period Fever with Aphtous stomatitis, Pharyngitis and cervical Adenitis), is a periodic syndrome described for the first time in 1987 by Marshall et al. It is characterized by regular recurrence of fever which associates with aphthous lesions,  pharyngitis and cervical adenitis. In 1999 the criteria for diagnosis of PFAPA were formulated by Thomas. PFAPA is considered peculiar to the pediatric age, but in the recent literature there are a few case reports of this syndrome in adults

Methods: We reviewed medical records of 239 children meeting clinical criteria for PFAPA syndrome

Results:

in our cohort (136 males and 103 females) fever began at a mean of 2.1 ±2 years of age. The majority of the children had a symptoms onset before the fifth year of life but 9% of the patients had a later onset. Since all the other clinical criteria but age were met in these latter patients, the diagnosis of PFAPA was confirmed. In 37% of the patients’ family history there was at least one first- or second-degree relative who underwent tonsillectomy for recurrent fevers or suffered from recurrent fevers in childhood. The PFAPA episodes lasted a mean of 4±2 days, with an interval between episodes of 28.3 days. Fever was accompanied by pharyngitis (98%),  cervical adenitis (64%),  aphthous stomatitis (39%) and  abdominal pain (33%). The parents reported in 10% of their children that some symptoms (irritability, nausea, headache) appeared 24-48 hours before fever onset and the parents learned to interpret these symptoms as prodromes of the PFAPA attack. All the patients were treated with oral steroids, using a single somministration of 1mg/kg of prednisone equivalent the first day of fever. All the patients had a prompt response to steroid treatment and only 12% of the patients experience a free-interval shortening.

In 57% of our patients the disease resolved spontaneously, after a mean period of 3 years. Medium age at PFAPA resolution was 5,7 ±3 years of age.

Among patients who underwent tonsillectomy (25%) only a single patient didn’t have complete resolution. Mutation analysis for FMF, HIDS and TRAPS in this patient was negative.

When clustering our population for age at onset (less than 1 yr, 1-5 years, more than 5 years) we observed that patients with onset within the first year had a significantly longer duration of disease (p<0.00002).

Conclusion: our study indicates that the 5 years of age cut-off is too strict for considering PFAPA diagnosis and that the onset before the first year of life predicts a longer disease duration. As previously reported abdominal pain are a relevant feature in PFAPA, almost as common as aphtous stomatitis. We also observed “prodromic symptoms” quite commonly. A significant proportion of  family histories is indicative of possible PFAPA Syndrome in the first or second degree relatives of our patients. In our experience prednisone in a single given dose is highly efficacious in managing patients with PFAPA, and the free interval reduction happens in a minority of patients. Finally, even though limited to few patients, tonsillectomy had a very high rate of success in our experience, probably due to very strict selection of patients undergoing tonsillectomy.


Disclosure:

F. Ricci,
None;

A. Meini,
None;

L. Verdoni,
None;

L. Dotta,
None;

M. Bolis,
None;

M. Berlucchi,
None;

G. Savoldi,
None;

M. Cattalini,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-characteristics-and-therapy-response-in-a-large-single-centre-cohort-of-patients-with-periodic-fever-with-aphtous-stomatitis-pharyngitis-and-cervical-adenitis-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology